TC
OME

TFS Capital’s Omega Protein OME Stock Holding History

TFS Capital’s Portfolio OME Stock Details OME Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q1 		– Sell
-52,783
Closed -$1.32M – 978
2016
Q4 		$1.32M Buy
52,783
+32,421
+159% +$766K 0.35% 84
2016
Q3 		$476K Buy
+20,362
New +$478K 0.11% 256
2016
Q2 		– Sell
-21,916
Closed -$371K – 1333
2016
Q1 		$371K Buy
+21,916
New +$449K 0.05% 564
2015
Q2 		– Sell
-70,099
Closed -$960K – 1207
2015
Q1 		$960K Buy
+70,099
New +$809K 0.09% 361
2014
Q4 		– Sell
-100,819
Closed -$1.26M – 1278
2014
Q3 		$1.26M Sell
100,819
-1,911
-2% -$26.6K 0.11% 297
2014
Q2 		$1.41M Sell
102,730
-87,388
-46% -$1.14M 0.11% 295
2014
Q1 		$2.29M Sell
190,118
-38,620
-17% -$442K 0.15% 190
2013
Q4 		$2.81M Buy
228,738
+138,032
+152% +$1.62M 0.13% 219
2013
Q3 		$922K Sell
90,706
-150,324
-62% -$1.41M 0.04% 612
2013
Q2 		$2.16M Buy
+241,030
New +$2.43M 0.09% 327

Other funds holding OME

Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
LSV Asset Management
LSV Asset Management Chicago, Illinois $46.4B AUM 27.74% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
NI
Numeric Investors Boston, Massachusetts $13.7B AUM 28.88% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return
JIR
James Investment Research Alpha, Ohio $891M AUM 30.4% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Allianz Asset Management
Allianz Asset Management Munich, Germany $95.4B AUM 38.74% 1-Year Est. Return

TFS Capital's OME Position: Q1 2017 in Review

TFS Capital sold out of Omega Protein (OME) in Q1 2017, closing a stake of 52,783 shares — an estimated $1.32M sold.

TFS Capital first reported a position in OME in Q2 2013 and held it in 10 quarters. The position peaked at $2.81M in Q4 2013. 144 funds tracked by Wall St. Rank hold OME as of Q1 2017.

  • TFS Capital reported no remaining Omega Protein position as of Q1 2017 after selling out during the quarter.
  • TFS Capital sold 52,783 Omega Protein shares in Q1 2017, an estimated $1.32M.
  • TFS Capital first reported a position in Omega Protein in Q2 2013 and held it in 10 quarters.
  • TFS Capital's Omega Protein position peaked at $2.81M in Q4 2013.
  • 144 funds tracked by Wall St. Rank held Omega Protein as of Q1 2017.

Based on TFS Capital's 13F filing for Q1 2017, filed 5 May 2017.